UBS raised the firm’s price target on Ares Commercial (ACRE) to $5 from $3.75 and keeps a Neutral rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACRE:
- Ares Commercial Real Estate Corp: Sell Rating Amid Challenging Market and Unattractive Valuation
- Ares Commercial Real Estate Reports Strong Q1 2025 Results
- Ares Commercial Real Estate’s Earnings Call Highlights
- Ares Commercial Reports Strong Q1 2025 Financial Results
- Ares Commercial reports Q1 distributable EPS 13c, consensus 7c